Testing version — LOERadar is in active testing. Features and data may change.
CLARITIN REDITABS (LORATADINE) | LOERadar
CLARITIN REDITABS
NDA
LORATADINE | N020704 | BAYER HEALTHCARE LLC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#003 — 10MG
RLD
0 patents0 exclusivities▾
TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Nov 19, 2003
#002 — 10MG
RLD
0 patents0 exclusivities▴
TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Nov 27, 2002
No patent or exclusivity listings for this strength.